Vascular endothelial growth factor and carotid intima-media thickness in patients with Behç's disease

Clinical Rheumatology

Volumn 27, Issue 8, 2008, Pages 961-966

  Öztürk, Mehmet Akif ^a,e   Ünverdi, Selman ^a   Oktar, Suna O ^a   Bukan, Neslihan ^a   Gülbahar, Özlem ^a   Üreten, Kemal ^b   Göker, Berna ^a   Haznedaroglu, Seminur ^a   Sungur, Gülten ^c   Çiftçi, Tansu Ulukavak ^a   Onat, A Mesut ^d  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d GAZIANTEP UNIVERSITY   (Turkey)

^e Cukurambar Mahallesi Ogretmenler Caddesi   (Turkey)

Author keywords

Atherosclerosis; Beh et's disease; Carotid intima media thickness; High resolution B mode ultrasonography; Vascular endothelial growth factor

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AZATHIOPRINE; BENZATHINE PENICILLIN; COLCHICINE; CYCLOSPORIN A; SALAZOSULFAPYRIDINE; STEROID; VASCULOTROPIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; BEHCET DISEASE; CAROTID ARTERY DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INFLAMMATION; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SAMPLE SIZE;

ADULT; ATHEROSCLEROSIS; BEHCET SYNDROME; BIOLOGICAL MARKERS; CAROTID ARTERIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; TUNICA INTIMA; TUNICA MEDIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 47349095807     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0825-5     Document Type: Article

References (38)

1. Özoran K, Düzgün H, Gürler A, Tutkak H, Tokgöz G (1995) Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease. Scand J Rheumatol 24:376-382
2. Haznedaroǧlu IC, Özdemir O, Özcebe O, Dündar SV, Kirazli Ş (1996) Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease. Thromb Haemost 75:974-975
3. Haznedaroǧlu Ş, Karaaslan Y, Büyükaşik Y, Kosar A, Ozcebe O, Haznedaroǧlu IC et al (2000) Selectin adhesion molecules in Behçet's disease. Ann Rheum Dis 59:61-63
4. Saglam K, Yilmaz MI, Saglam A, Ulgey M, Bulucu F, Baykal Y (2000) Levels of circulating intercellular adhesion molecule-1 in patients with Behcet's disease. Rheumatol Int 21:146-148
5. Haznedaroǧlu IC, Dündar SV, Kirazli Ş (1995) Eicosanoids in the prethrombotic state of Behçet's disease. Thromb Res 80:445-446
6. Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol 37:517-520
7. Kiraz S, Ertenli I, Ozturk MA, Haznedaroglu IC, Celik I, Calguneri M (2002) Pathological haemostasis and "prothrombotic state" in Behcet's disease. Thromb Res 105:125-133
8. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R et al (1996) The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271:7788-7795
9. Tsai WC, Li YH, Huang YY, Lin CC, Chao TH, Chen JH (2005) Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension. Clin Sci (Lond) 109:39-43
10. Bozoglu E, Dinc A, Erdem H, Pay S, Simsek I, Kocar IH (2005) Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behcet's patients with venous thrombosis. Clin Exp Rheumatol 23(4 Suppl 38):S42-48
11. Cekmen M, Evereklioglu C, Er H, Inalöz HS, Doganay S, Türköz Y et al (2003) Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behcet's syndrome. Int J Dermatol 42:870-875
12. Erdem F, Gundogdu M, Kiki I, Ali Sari R, Kiziltunc A (2005) Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behcet's disease. Rheumatol Int 25:599-603
13. Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD (2002) Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmunity Reviews 1:338-347
14. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
15. Ross R (1993) The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809
16. Kamat BR, Galli SJ, Barger AC, Lainey LL, Silverman KJ (1987) Neovascularization and coronary atherosclerotic plaque: Cinematographic localization and quantitative histologic analysis. Hum Pathol 18:1036-1042
17. Moulton KS (2001) Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep 3:225-233
18. Inoue M, Itoh H, Tanaka T, Chun TH, Doi K, Fukunaga Y et al (2001) Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol 21:560-566
19. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr et al (1992) Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 23:1752-1760
20. Bots ML, Hofman A, De Jong PT, Grobbee DE (1996) Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery. The Rotterdam Study. Ann Epidemiol 6:147-153
21. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C (1991) Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 134:250-256
22. Li R, Cai J, Tegeler C, Sorlie P, Metcalf PA, Heiss G (1996) Reproducibility of extracranial carotid atherosclerotic lesions assessed by B-mode ultrasound: The Atherosclerosis Risk in Communities Study. Ultrasound Med Biol 22:791-799
23. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R (1986) Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 74:1399-1406
24. Persson J, Formgren J, Israelsson B, Berglund G (1994) Ultrasound determined intima-media thickness and atherosclerosis: Direct and indirect validation. Arterioscler Thromb 14:261-264
25. Ozturk MA, Oktar SO, Unverdi S, Ureten K, Goker B, Haznedaroglu S et al (2006) Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet's disease. Rheumatol Int 26:867-872
26. Keser G, Aksu K, Tamsel S, Ozmen M, Kitapcioglu G, Kabaroglu C et al (2005) Increased thickness of the carotid artery intima-media assessed by ultrasonography in Behcet's disease. Clin Exp Rheumatol 23(4 Suppl 38):S71-76
27. Alan S, Ulgen MS, Akdeniz S, Alan B, Toprak N (2004) Intima-media thickness and arterial distensibility in Behcet's disease. Angiology 55:413-419
28. International Study Group for Behcet's disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080
29. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
30. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22
31. Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW et al (1997) Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol 150:1673-1685
32. Chen YX, Nakashima Y, Tanaka K, Shiraishi S, Nakagawa K, Sueishi K (1999) Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler Thromb Vasc Biol 19:131-139
33. Marumo T, Schini-Kerth VB, Busse R (1999) Vascular endothelial growth factor activates nuclear factor-kappa B and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48:1131-1137
34. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614-7620
35. Salvarani C, Boiardi L, Casali B, Olivieri I, Cantini F, Salvi F et al (2004) Vascular endothelial growth factor gene polymorphisms in Behcet's disease. J Rheumatol 31:1785-1789
36. Xiong M, Elson G, Legarda D, Leibovich SJ (1998) Production of vascular endothelial growth factor by murine macrophages: Regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 153:587-598
37. Webb NJ, Myers CR, Watson CJ, Bottomley MJ, Brenchley PE (1998) Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 10:254-257
38. Gul A (2001) Behçet's disease: An update on the pathogenesis. Clin Exp Rheumatol 19:S6-12